Understanding payer value and evidence requirements to secure pricing and reimbursement for a novel uterine fibroids treatment across Europe by developing a payer value proposition.
In order to increase the uptake at national, regional, and local levels, our client wanted to understand the clinical and economic evidence requirements that drive payer decision making for a novel treatment that had previously obtained market authorisation across Europe.
Value to the Client
Partnering with Remap Consulting enabled our client to:
- Understand the current treatment landscape
- Obtain focused payer insights for the product
- Identify EU payer evidence requirements to secure optimal pricing and reimbursement
- Effectively communicate the payer value of the product
Excellent work, the project ran very smoothly and we appreciated your efficient approach to managing the project and delivery of final proposition.CEO, Large Pharma
View our Payer Value Communication Strategy services.